MAPK7 and cholangiocarcinoma: ERK5 is consistently expressed in several tumor types, including melanoma, osteosarcoma, mesothelioma, RCC, hepatocellular carcinoma (HCC), brain tumors, BC, LC, cholangiocarcinoma (CCA), and PCa (Table 1).